| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe107b1e9a987478a517c506fec695ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33acdc1f4b9c1fc997407b22054f65b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5e95156255d5fe8b2923c544786e176 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70514 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-73 |
| filingDate |
1996-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b62f38031ae0a05643d8b7feb69aa3f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e128867342aeec9ade299401b8b6d88b |
| publicationDate |
1996-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9620722-A1 |
| titleOfInvention |
Compounds that inhibit t cell proliferation and methods using the same |
| abstract |
Compounds are disclosed which are useful to inhibit T cell proliferation. The compounds may be formulated with pharmaceutically acceptable carriers to form pharmaceutical compositions. Method of treating an individual suspected of suffering from or being susceptible to a condition characterized by undesired immune response are disclosed. Methods of treating individuals suffering from HIV infection are also disclosed. The methods comprise the step of administering to such an individual a pharmaceutical composition comprising the compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7700087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7067117-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7238711-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0228385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6989435-B2 |
| priorityDate |
1995-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |